Trial NCT03009058

View at ClinicalTrials.gov 
Org. Study IDs: IMM-101-011
Secondary IDs: 2016 001459 28 CANC 32085

Last trial update was posted on 2018-08-09

MeSH Interventions

Albumin-Bound Paclitaxel Capecitabine Cetuximab Cyclophosphamide Fluorouracil Folic Acid Gemcitabine Ipilimumab Irinotecan Leucovorin Levoleucovorin Nivolumab Oxaliplatin Pembrolizumab

MeSH Conditions

Neoplasm Metastasis

Other Conditions

Metastatic Cancer

Stopping Reasons

Commercial reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID